Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer‐initiating cells
Open accessThe DOI matches its Crossref record.
Abstract
Pancreatic adenocarcinoma (PaCa) being the deadliest cancer is partly due to early metastatic spread. Thus, we searched for PaCa‐initiating cell (PaCIC) markers with emphasis on markers contributing to metastatic progression. PaCIC were enriched from long‐term and freshly established lines by repeated selection for spheroid or holoclone growth in advance of evaluating PaCIC markers. Sphere and holoclone formation steeply increased by recloning and remained stable thereafter. Cells not forming spheres or holoclones died on recloning. PaCIC enrichment in spheres and holoclones was accompanied by increased motility, anchorage independence and upregulated CXCR4 expression. After subcutaneous injection in NOD/SCID mice tumorigenicity and, impressively, recovery of metastasizing tumor cells in peripheral blood, spleen, bone marrow, lung and pancreas was strongly increased in spheres and holoclones. PaCIC enrichment in spheres and holoclones was accompanied, besides CXCR4, by upregulated CD44v6, alpha6beta4, weakly CD133 and tetraspanin Tspan8 expression. Notably, CD44v6, alpha6beta4, CXCR4 and Tspan8 expressing PaCa cells had a growth advantage in vivo and became dominating in migrating and in distant organs settled tumor cells. This is the first report showing that CD44v6, alpha6beta4, Tspan8 and CXCR4 are biomarkers in PaCIC allowing for long‐term survival, expansion and migration in immunocompromised mice. The stability of the percentage of PaCIC in long‐term and freshly established lines after a roughly 8‐fold enrichment by cloning indicates PaCIC, though required for long‐term survival, concomitantly depending on support by non‐CIC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Seguin, L., Desgrosellier, J. S., Weis, S. M., & Cheresh, D. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.006 · Cited by 685
Madhavan, B., Yue, S., Galli, U., Rana, S., Gross, W., Müller, M., Giese, N. A., Kalthoff, H., Becker, T., Büchler, M. W., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29324 · Cited by 495
Self-citationYue, S., Mu, W., Erb, U., & Zöller, M. (2015) · Oncotarget · doi:10.18632/oncotarget.2958 · Cited by 181
Self-citationSOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer
Li, J., Chen, X., Zhu, L., Lao, Z., Zhou, T., Zang, L., Ge, W., Jiang, M., Xu, J., Cao, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01864-9 · Cited by 45
Self-citationYang, J., Guo, F., Chin, H. S., Chen, G. B., Ang, C. H., Lin, Q., Hong, W., & Fu, N. Y. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112065 · Cited by 22
Molecular Regulation and Oncogenic Functions of TSPAN8
Yang, J., Zhang, Z., Lam, J. S. W., Fan, H., & Fu, N. Y. (2024) · Cells · doi:10.3390/cells13020193 · Cited by 11
“In another study, TSPAN8, alongside CD44v6, an α 6 β 4 integrin, and CD133, were found to be upregulated in pancreatic cancer-initiating cells (Pa-CIC), where they conferred in vivo growth and metastatic advantages [148].”
Background
Metadata
- Authors
- Wang, H., Rana, S., Giese, N., Büchler, M. W., & Zöller, M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2013-02-15
- Volume
- 133
- Issue
- 2
- Pages
- 416-426
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1956445706
- Cited by
- 88
- References
- 0
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.